News about "AML maintenance therapy"

Innovent and Daiichi Sankyo Partner for Vanflyta Commercialisation in China

Innovent and Daiichi Sankyo Partner for Vanflyta Commercialisation in China

Innovent Biologics and Daiichi Sankyo have entered an exclusive agreement to commercialise Vanflyta in China, expanding access for FLT3-ITD positive AML patients.

AML Maintenance Therapy | 11/08/2026 | By News Bureau


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members